Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-07-03
2007-07-03
Huff, Sheela J. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210
Reexamination Certificate
active
10668057
ABSTRACT:
The present invention provides methods and kits for predicting recurrence of tumor or cancer in a mammal by calculating the ratio of the amount of Survivin to the amount of pro-apoptosis factor (PAF) in a physiological sample.
REFERENCES:
patent: 6001962 (1999-12-01), Ramer et al.
patent: 6077709 (2000-06-01), Bennett et al.
patent: 6103237 (2000-08-01), Saedi et al.
patent: 6656684 (2003-12-01), Sandler
Krieg A et al. British Journal of Cancer 86: 737-743, 2002.
Mahotka C et al. Cancer Research 59: 6097-6102, 1999.
Fu L et al. EMBO Journal 15(16): 4392-4401, 1996.
Powell H et al. Pharmacogenetics 8(5): 411-421, 1998 (Abstract only enclosed).
Vallejo CG et al. Biochimie 82(12): 1129-1133, 2000 (Abstract only enclosed).
Jang A et al. Clin Exp Metastasis 15(5): 469-483, 1997 (Abstract only enclosed).
Altieri DC Trends in Molecular Medicine 7(12): 542-547, 2001.
Lu C et al. Cancer Research 58: 1808-1812, 1998.
LaCasse EC et al. Oncogene 17, 3247-3259, 1998.
Adida C et al. The Lancet 351: 882-883, 1998.
Tamm I et al. Cancer Research 5315-5320, 1998.
Adida, C. , et al., “Anti-apoptosis gene, survivin, and prognosis of neuroblastoma”,The Lancet, 351, (1998),pp. 882-883.
Ambrosini, G. , et al., “A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma”,Nature Medicine, 3 (8), (1997),pp. 917-921.
Ashkenazi, A. , et al., “Death Receptors: Signaling and Modulation”,Science, 281 (5381), (1998),pp. 1305-1308.
Breslow, N. , et al., “Epidemiology of Wilms Tumor”,Medical and Pediatric Oncology, 21 (3), (1993),pp. 172-181.
Brodeur, G. M., et al., “Neuroblastoma”,In: Principles and Practice of Pediatric Oncology, Chapter 29, (1997),pp. 761-797.
Deveraux, Quinn L., et al., “X-Linked IAP is a Direct Inhibitor of Cell-Death Proteases”,Nature, 388 (6639), (1997),pp. 300-304.
Donaldson, S. A., et al., “Expression of Fas/APO-1 by different clinical stages of human neuroblastoma”,Proceedings of the American Association for Cancer Research, 40, Abstract No. 1141,(Mar. 1999),p. 171.
Li, F. , et al., “Control of apoptosis and mitotic spindle checkpoint by survivin”,Nature, 396, (1998),pp. 580-584.
Li, F. , et al., “Pleiptropic cell-devision defects and apoptosis induced by interference with survivin function”,Nature Cell Biology, 1 (8), (1999),pp. 461-466.
Liston, P. , et al., “Supression of apoptosis in mammalian cells by NAIP and a related family of IAP genes”,Nature, 379, (1996),pp. 349-353.
Lowry, O. H., et al., “Protein Measurements With The Folin Phenol Reagent”,The Journal of Biological Chemistry, 193, (1951),pp. 265-275.
Lu, C. , et al., “Expression of A Novel Antiapoptosis Gene, Survivin, Correlated with Tumor Cell Apoptosis and p53 Accumulation in Gastric Carcinomas”,Cancer Research, 58 (9), (1998),pp. 1808-1812.
Miller, L. J., et al., “Apoptosis”,Science, 281 (5381), (1998),p. 1301.
Sandler, A. , et al., “Survivin in Apoptosis and Solid Tumors of Childhood”.Surgical Forum, 85th Annual Clinical Congress, vol. L, (1999),pp. 571-572.
Sarela, et al., “Expression of the Antiapoptosis Gene, Survivin, Predicts Death from Recurrent Colorectal Carcinoma”,Gut, 46, (May 2000),645-650.
Swana, H. S., et al., “Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer”,The New England Journal of Medicine, 341 (6), (1999),pp. 452-453.
Takamizawa, S. , et al., “Differential Apoptosis Gene Expression in Pediatric Tumors of the Kidney”,Journal of Pediatric Surgery, 35 (2), (Feb. 2000),pp. 390-395.
Tamm, I. , et al., “IAP-Family Protein Survivin Inhibits Caspase Activity and Apoptosis Induced by Fas (CD95), Bax, Caspases, and Anticancer Drugs”,Cancer Research, 58 (23), (1998),pp. 5315-5320.
Thompson, C. B., “Apoptosis in the Pathogenesis and Treatment of Disease”,Science, 267, (1995),pp. 1456-1462.
Azuhata et al., “The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma”,J. Pediatr Surg., 36 (12), 1785-1791 (2001).
Sandler et al., “The survivin:fas ratio is predictive of recurrent disease in neuroblastoma”,J. Pediatr Surg., 37(3), 507-511 (2002).
Takamizawa et al., “The survivin:fas ratio in pediatric renal tumors”,J Pediatr Surg., 36(1), 37-42 (2001).
Huff Sheela J.
University of Iowa Research Foundation
Viksnins Harris & Podys PLLP
LandOfFree
Method for predicting tumor recurrence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for predicting tumor recurrence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting tumor recurrence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772077